Medicare Enrolled

Dr. Rajeev Singh, M.D.

Cardiovascular Disease · Atlanta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
95 COLLIER RD NW STE 3000, Atlanta, GA 30309
4046055422
In practice since 2013 (13 years)
NPI: 1194169417 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Singh

Dr. Rajeev Singh is a cardiovascular disease specialist in Atlanta, GA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 1,616 Medicare services across 562 unique beneficiaries.

Between the years covered by Open Payments, Dr. Singh received a total of $9,808 from 31 pharmaceutical and/or device companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ 1,616 Medicare services $9,808 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,616
Medicare services
Bottom 43% in GA for cardiovascular disease
562
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~124 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
553 $95 $355
Evaluation of lower heart chamber assist device
Assessment of the function and status of a device that assists the lower chambers of the heart.
378 $32 $187
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
216 $170 $762
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
129 $96 $371
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
104 $8 $23
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
60 $108 $380
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
41 $63 $249
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
36 $63 $291
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
25 $138 $691
Heart muscle biopsy
A procedure to remove a small sample of heart muscle tissue for laboratory examination.
24 $177 $792
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
20 $127 $561
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
18 $91 $366
Sedation by physician, initial 15 minutes
Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older.
12 $10 $137
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,808
Total received (2018-2024)
Avg $1,401/year across 7 years
Top 21% in GA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
362
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,588 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$220 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,893
2023
$2,062
2022
$2,004
2021
$955
2020
$275
2019
$773
2018
$1,846

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$415
AstraZeneca Pharmaceuticals LP
$261
Alnylam Pharmaceuticals Inc.
$240
Merck Sharp & Dohme LLC
$199
Boehringer Ingelheim Pharmaceuticals, Inc.
$190
Abbott Laboratories
$145
E.R. Squibb & Sons, L.L.C.
$124
CVRx, Inc.
$95
PFIZER INC.
$51
Novo Nordisk Inc
$42
Boston Scientific Corporation
$31
Impulse Dynamics (USA) Inc.
$26
Amgen Inc.
$23
Lexicon Pharmaceuticals, Inc.
$16
Medtronic, Inc.
$16
Kiniksa Pharmaceuticals International, plc
$15
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$5
Top 3 companies account for 48.4% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$3,186
Novartis Pharmaceuticals Corporation
$1,384
CVRx, Inc.
$678
Merck Sharp & Dohme LLC
$598
Alnylam Pharmaceuticals Inc.
$548
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$544
Boehringer Ingelheim Pharmaceuticals, Inc.
$492
AstraZeneca Pharmaceuticals LP
$487
E.R. Squibb & Sons, L.L.C.
$452
Medtronic, Inc.
$221
PFIZER INC.
$182
Amgen Inc.
$165
Penumbra, Inc.
$161
Boston Scientific Corporation
$127
Impulse Dynamics (USA) Inc.
$68
Daiichi Sankyo Inc.
$62
Kestra Medical Technology Services, Inc.
$56
Eurofins Viracor, LLC
$54
Janssen Pharmaceuticals, Inc
$46
Novo Nordisk Inc
$42
Lexicon Pharmaceuticals, Inc.
$39
Kiniksa Pharmaceuticals, Ltd.
$32
La Jolla Pharmaceutical Company
$30
Edwards Lifesciences Corporation
$27
Bayer HealthCare Pharmaceuticals Inc.
$24
GENZYME CORPORATION
$22
Phadia US Inc.
$20
ABIOMED
$20
Nuwellis, Inc.
$16
Kiniksa Pharmaceuticals International, plc
$15
BOSTON SCIENTIFIC CORPORATION
$13
Top 3 companies account for 53.5% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · Aquadex Smartflow Console · Arcalyst · Assure WCD · Assurity Pacemaker · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · COBALT DR MRI SURESCAN · CardioMEMS HF System · ELIQUIS · ELLIPSYS VASCULAR ACCESS SYSTEM · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ensite Cardiac Mapping System · FARXIGA · GIAPREZA · HEARTMATE TOUCH · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · HeartMate PHP · HeartMate Touch · Hi-Torque Cross-It guide wires · INJECTAFER · ImmunoCAP · Impella · Indigo System · Inpefa · JARDIANCE · LEQVIO · LifeVest · MITRACLIP · Micra · No Associated Abbott Product · ONPATTRO · Optimizer · Ozempic · Repatha · Rybelsus · Safire Ablation Catheter · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VARITHENA · VENASEAL · VERQUVO · VYNDAQEL · Varithena Administration Pack · Verquvo · WAINUA · XARELTO · XERAVA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cardiovascular disease specialist in Atlanta?
Compare cardiologists in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
337
Per 100K population
31.5
County median income
$91,490
Nearest hospital
PIEDMONT HOSPITAL, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Singh is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Singh experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Singh performed 553 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $9,808 from 31 companies across 362 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other cardiologists in Atlanta?
Dr. Singh's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →